Send the following on WhatsApp
Continue to ChatAZ Durvalumab 結合鉑類化療藥物,延長非小細胞肺癌患者無事件存活期 https://geneonline.news/az-durvalumab-improve-efs-nsclc/?variant=zh-cn
AZ Durvalumab 結合鉑類化療藥物,延長非小細胞肺癌患者無事件存活期 https://geneonline.news/az-durvalumab-improve-efs-nsclc/?variant=zh-cn